Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9316)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 20, 2014 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Digklia A, Voutsadakis IA. Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status. World J Exp Med 2014; 4(4): 58-67 [PMID: 25414818 DOI: 10.5493/wjem.v4.i4.58] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v4/i4/58.htm |
| Number | Citing Articles |
| 1 |
Karolina Vernmark, Maria Albertsson, Bergthor Björnsson, Thomas Gasslander, Per Sandström, Xiao-Feng Sun, Annika Holmqvist. From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1908-3
|
| 2 |
Donald T. Yapp, May Q. Wong, Alastair H. Kyle, Shannon M. Valdez, Jenny Tso, Andrew Yung, Piotr Kozlowski, David A. Owen, Andrzej K. Buczkowski, Stephen W. Chung, Charles H. Scudamore, Andrew I. Minchinton, Sylvia S. W. Ng. The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth. Angiogenesis 2016; 19(2): 229 doi: 10.1007/s10456-016-9503-z
|
| 3 |
Diana Klein. Endothelial Signaling in Vascular Dysfunction and Disease. 2021; : 91 doi: 10.1016/B978-0-12-816196-8.00015-1
|
| 4 |
King-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, Li-Wen Hsu, Chia-Yun Lai, Ching-Yin Huang, Yu-Fan Cheng, Shigeru Goto, Chao-Long Chen, Kwan Man. Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver Transplantation. PLOS ONE 2015; 10(5): e0124943 doi: 10.1371/journal.pone.0124943
|
| 5 |
Dietmar W. Siemann, Michael R. Horsman. Modulation of the tumor vasculature and oxygenation to improve therapy. Pharmacology & Therapeutics 2015; 153: 107 doi: 10.1016/j.pharmthera.2015.06.006
|
| 6 |
Anna Dmoszyńska, Elżbieta Starosławska, Krzysztof Giannopoulos. Terapia metronomiczna w hematoonkologii: nadzieje i fakty. Acta Haematologica Polonica 2015; 46(5): 353 doi: 10.1016/j.achaem.2015.10.004
|
| 7 |
Kai Wang, Xiao Qu, Ying Wang, Wei Dong, Hongchang Shen, Tiehong Zhang, Yang Ni, Qi Liu, Jiajun Du. The Impact of Ramucirumab on Survival in Patients with Advanced Solid Tumors: A Systematic Review and Meta-Analysis of Randomized II/III Controlled Trials. Clinical Drug Investigation 2016; 36(1): 27 doi: 10.1007/s40261-015-0355-x
|
| 8 |
Gijung Kwak, Sung Duk Jo, Dongkyu Kim, Hyosuk Kim, Myung Goo Kim, Kwangmeyung Kim, Ick Chan Kwon, Sun Hwa Kim. Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles. Journal of Controlled Release 2017; 267: 203 doi: 10.1016/j.jconrel.2017.08.015
|